微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.59% | -29.76% | 5.36% | 87/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 0.56% | -37.08% | -38.46% | 82/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 0.91% | -77.42% | -32.59% | 87/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 1.35% | -68.09% | 60.71% | 90/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.84% | -74.62% | -5.62% | 90/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.89% | -48.26% | -77.92% | 74/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 4.03% | 61.85% | -4.73% | 69/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.23% | 41.95% | 27.79% | 66/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.31% | 77.01% | 92.44% | 59/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.72% | 57.8% | -30.92% | 57/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.49% | -49.29% | -16.44% | 93/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 2.98% | -17.91% | 59.36% | 89/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.87% | -39.09% | 71.56% | 87/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.09% | -50.45% | -77.8% | 83/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 4.91% | -41.41% | 35.26% | 95/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 3.63% | -42.83% | 18.24% | 96/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 3.07% | -0.65% | 39.55% | 86/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.2% | 16.4% | -73.75% | 67/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 8.38% | 83.77% | 31.97% | 91/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 6.35% | 59.15% | 105.5% | 86/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.09% | 5.82% | 63.49% | 100/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.89% | 3.85% | -58.55% | 78/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 4.56% | -20.83% | 14.29% | 112/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 3.99% | -13.82% | 36.64% | 73/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 2.92% | -7.01% | 60.44% | 88/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.82% | -22.22% | -68.4% | 43/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 5.76% | -32% | 24.41% | 94/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.63% | -32.8% | 47.45% | 52/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 3.14% | -34.85% | 34.19% | 53/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.34% | 8.84% | -72.37% | 27/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 8.47% | -24.58% | 22.93% | 75/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 6.89% | -37.25% | 42.95% | 35/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.82% | -37.56% | 124.19% | 28/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 2.15% | 2% | -80.85% | 28/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 11.23% | -19.21% | 2.28% | 61/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 10.98% | 2% | 42.23% | 20/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 7.72% | 2% | -44.46% | 22/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2016-12-31 | 13.9% | 5.22% | 5.22% | 40/141 | 16.44% | 基蛋生物 | 11.34% | 行业排名> |